Stock info Magnit | Filter  Basic-Info

Magnit

Between 2006 and 2016 the global food & drug retailers gained around 32 percent. Measured since 2011 the sector is 27 percent higher and over the past 12 months (December 2015-2016) there is a minus of 32 percent.

The past year was a profitable year for the Magnit investors

The period between December 2015 and December 2016 was a bad period for the investors. The stock lost almost 1 percent. The period between August 2011 and August 2016 was a profitable period for the investors. The stock rose on average 286 percent. Magnit's revenues between 2011 and 2015 were quite unstable and moved between 448,1 billion rubels and 953,74 billion rubels. The net results between 2011 and 2015 were far from constant and fluctuated between 12,31 billion rubels and 0 million rubels.

Over the past 5 years the Russian company paid out dividends. Over the past 5 years Magnit's dividend yield was at around 874,05 percent per year.

At the end of 2015 around 105,5 thousand people were employed at Magnit.

Magnit' balance mostly financed with equity

At the end of 2015 the Russian company had a balance sheet of around 404,56 billion rubels. Last year the total debt of the company was 239,27 billion rubels. This equals around 59,14 percent of the total balance sheet. Last year the food & drug retailer's price/earnings-ratio (PE) was around 16. So the investors valued the stock at 16 times 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the Russian stock can be seen as a value stock.

At the end of 2015 the food & drug retailer's market size (her number of outstanding share times the stock price) equaled around 1079,77 billion rubels. At the end of 2015 the Russian company had around 95 million stocks listed on the stock exchange(s).

All the annual reports of Magnit are available here. More information about Magnit can be found it's website. .